These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16779728)

  • 41. [Comparative serological and parasitological study of 2 villages with hyperendemic onchocerciasis in Mali (savanna area) and Ivory Coast (preforest area). Relationship with the severity of the disease].
    Prod'hon J; Ambroise-Thomas P; Lardeux F
    Ann Soc Belg Med Trop; 1982 Dec; 62(4):343-52. PubMed ID: 6301391
    [No Abstract]   [Full Text] [Related]  

  • 42. The use of fixed-tissue sections to determine antibodies to Onchocerca volvulus in a fluorescent antibody test.
    Collins WE; Skinner JC
    J Parasitol; 1979 Oct; 65(5):827-9. PubMed ID: 390111
    [No Abstract]   [Full Text] [Related]  

  • 43. The use of a topical Mazzotti test in the diagnosis of onchocerciasis.
    Kilian HD
    Trop Med Parasitol; 1988 Sep; 39(3):235-8. PubMed ID: 3194667
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epilepsy and retarded growth in a hyperendemic focus of onchocerciasis in rural western Uganda.
    Ovuga E; Kipp W; Mungherera M; Kasoro S
    East Afr Med J; 1992 Oct; 69(10):554-6. PubMed ID: 1473507
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tandem Use of OvMANE1 and Ov-16 ELISA Tests Increases the Sensitivity for the Diagnosis of Human Onchocerciasis.
    Shintouo CM; Ghogomu SM; Shey RA; Hotterbeekx A; Yagmur E; Mets T; Vanhamme L; Colebunders R; Souopgui J; Njemini R
    Life (Basel); 2021 Nov; 11(12):. PubMed ID: 34947815
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Results of 2 eye examinations carried out with an interval of 6 years in 2 Upper Volta villages where onchocerciasis is endemic].
    Rolland A
    Bull World Health Organ; 1974; 51(3):257-61. PubMed ID: 4549349
    [No Abstract]   [Full Text] [Related]  

  • 47. Differences in the Clinical and Laboratory Features of Imported Onchocerciasis in Endemic Individuals and Temporary Residents.
    Showler AJ; Kubofcik J; Ricciardi A; Nutman TB
    Am J Trop Med Hyg; 2019 May; 100(5):1216-1222. PubMed ID: 30761981
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Topical application of diethylcarbamazine to detect onchocerciasis recrudescence in west Africa.
    Toè L; Adjami AG; Boatin BA; Back C; Alley ES; Dembélé N; Brika PG; Pearlman E; Unnasch TR
    Trans R Soc Trop Med Hyg; 2000; 94(5):519-25. PubMed ID: 11132381
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Field diagnosis of onchocerciasis in an area of high versus low endemicity: evaluation of the Dot Blot Assay.
    Lavebratt C; Dalhammar G; Awadzi K; Akuffo HO
    Scand J Infect Dis; 1996; 28(1):75-81. PubMed ID: 9122638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of a recombinant antigen (OC 3.6 cDNA) for the serological diagnosis of onchocerciasis in exposed Nigerian children.
    Ogunrinade AF; Chandrashekar R; Weil GJ; Kale OO
    J Trop Pediatr; 1992 Jun; 38(3):103-5. PubMed ID: 1507301
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The burden of blindness in adult males in the savanna villages of West Africa exposed to onchocerciasis.
    Prost A
    Trans R Soc Trop Med Hyg; 1986; 80(4):525-7. PubMed ID: 3810784
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In Silico Design and Validation of OvMANE1, a Chimeric Antigen for Human Onchocerciasis Diagnosis.
    Shintouo CM; Shey RA; Nebangwa DN; K Esoh K; Nongley NF; Nguve JE; Giron P; Mutesa L; Vanhamme L; Souopgui J; Ghogomu SM; Njemini R
    Pathogens; 2020 Jun; 9(6):. PubMed ID: 32580355
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The economics of blindness prevention in Upper Volta under the Onchocerciasis Control Program.
    Prescott N; Prost A; Le Berre R
    Soc Sci Med; 1984; 19(10):1051-5. PubMed ID: 6098020
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epilepsy in a focus of onchocerciasis in Burkina Faso.
    Kabore JK; Cabore JW; Melaku Z; Druet-Cabanac M; Preux PM
    Lancet; 1996 Mar; 347(9004):836. PubMed ID: 8622372
    [No Abstract]   [Full Text] [Related]  

  • 55. A new immunodiagnostic test in onchocerciasis.
    Somorin AO; Heiner DC
    Clin Allergy; 1976 Nov; 6(6):573-6. PubMed ID: 1016289
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lepromatous leprosy and onchocerciasis.
    Prost A; Nebout M; Rougemont A
    Br Med J; 1979 Mar; 1(6163):589-90. PubMed ID: 570867
    [No Abstract]   [Full Text] [Related]  

  • 57. Indirect fluorescent antibody test for the sero-diagnosis of onchocerciasis.
    Woodruff AW; Wiseman RA
    Exp Parasitol; 1968 Jun; 22(3):295-8. PubMed ID: 4876988
    [No Abstract]   [Full Text] [Related]  

  • 58. IMMUNOFLUORESCENCE IN ONCHOCERCIASIS.
    LUCASSE C; HOEPPLI R
    Z Tropenmed Parasitol; 1963 Jul; 14():262-9. PubMed ID: 14047095
    [No Abstract]   [Full Text] [Related]  

  • 59. Fluorescent antibody test for onchocerciasis.
    LUCASSE C
    Z Tropenmed Parasitol; 1962 Dec; 13():404-8. PubMed ID: 13931411
    [No Abstract]   [Full Text] [Related]  

  • 60. Field sensitivity and specificity of the SD BIOLINE onchocerciasis IgG4 Rapid Diagnostic Test in children <10 years old from endemic areas in Burkina Faso.
    Nikièma AS; Koala L; Unnasch TR; Diendéré J; Compaoré J; Ouédraogo MW; Kafando CM; Bakajika D; Bougouma C; Faye B; Traoré S; Dabiré RK
    Parasite Epidemiol Control; 2024 May; 25():e00352. PubMed ID: 38708128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.